This company seems to have been delisted
Reason: Rebranded as GeneDx
Last recorded trade on: March 14, 2023
Source: https://ir.genedx.com/news-releases/news-release-details/sema4-announces-name-change-genedx-and-provides-preliminary-2022
Reason: Rebranded as GeneDx
Last recorded trade on: March 14, 2023
Source: https://ir.genedx.com/news-releases/news-release-details/sema4-announces-name-change-genedx-and-provides-preliminary-2022
Sema4
SMFR
₹27.00
Share price
26.78%
Change (1 day)
-86.98%
Change (1 year)
Categories
Sema4 (SMFR) - Cash on Hand
Cash on Hand as of September 2022 : ₹16.63 Billion
According to Sema4's latest financial reports the company has ₹16.63 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sema4 - Cash on Hand chart (from 2020 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | ₹29.81 B | 277.02% |
| 2020-12-31 | ₹7.90 B |